Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Want to see HK:3692 full AI Analyst Report?
Total Valuation
Hansoh Pharmaceutical Group Company Limited has a market cap or net worth of HK$203.76B. The enterprise value is HK$176.13B.
Market CapHK$203.76B
Enterprise ValueHK$176.13B
Share Statistics
Hansoh Pharmaceutical Group Company Limited has 6,064,150,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,064,150,000
Owned by Insiders―
Owned by Institutions4.50%
Financial Efficiency
Hansoh Pharmaceutical Group Company Limited’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 12.91%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)12.91%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee1.67M
Profits Per Employee728.73K
Employee Count8,989
Asset Turnover0.38
Inventory Turnover2.49
Valuation Ratios
The current PE Ratio of Hansoh Pharmaceutical Group Company Limited is 34.9. Hansoh Pharmaceutical Group Company Limited’s PEG ratio is 1.36.
PE Ratio34.9
PS Ratio12.90
PB Ratio5.48
Price to Fair Value5.48
Price to FCF31.01
Price to Operating Cash Flow44.94
PEG Ratio1.36
Income Statement
In the last 12 months, Hansoh Pharmaceutical Group Company Limited had revenue of 15.03B and earned 5.56B in profits. Earnings per share was 0.93.
Revenue15.03B
Gross Profit13.51B
Operating Income5.42B
Pretax Income6.55B
Net Income5.56B
EBITDA5.77B
Earnings Per Share (EPS)0.93
Cash Flow
In the last 12 months, operating cash flow was 3.95B and capital expenditures -183.21M, giving a free cash flow of 3.77B billion.
Operating Cash Flow3.95B
Free Cash Flow3.77B
Free Cash Flow per Share0.62
Dividends & Yields
Hansoh Pharmaceutical Group Company Limited pays an annual dividend of HK$0.232, resulting in a dividend yield of 0.97%
Dividend Per ShareHK$0.232
Dividend Yield0.97%
Payout Ratio25.85%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change34.15%
50-Day Moving Average35.87
200-Day Moving Average37.05
Relative Strength Index (RSI)32.29
Average Volume (3m)9.67M
Important Dates
Hansoh Pharmaceutical Group Company Limited upcoming earnings date is Aug 20, 2026, TBA (Confirmed).
Last Earnings DateMar 29, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
Hansoh Pharmaceutical Group Company Limited as a current ratio of 8.09, with Debt / Equity ratio of 0.30%
Current Ratio8.09
Quick Ratio7.95
Debt to Market Cap<0.01
Net Debt to EBITDA-0.57
Interest Coverage Ratio1.71K
Taxes
In the past 12 months, Hansoh Pharmaceutical Group Company Limited has paid 995.12M in taxes.
Income Tax995.12M
Effective Tax Rate0.15
Enterprise Valuation
Hansoh Pharmaceutical Group Company Limited EV to EBITDA ratio is 33.04, with an EV/FCF ratio of 30.48.
EV to Sales12.68
EV to EBITDA33.04
EV to Free Cash Flow30.48
EV to Operating Cash Flow28.27
Balance Sheet
Hansoh Pharmaceutical Group Company Limited has HK$31.58B in cash and marketable securities with HK$105.14M in debt, giving a net cash position of HK$31.47B billion.
Cash & Marketable SecuritiesHK$31.58B
Total DebtHK$105.14M
Net CashHK$31.47B
Net Cash Per ShareHK$5.19
Tangible Book Value Per ShareHK$5.86
Margins
Gross margin is 89.89%, with operating margin of 36.04%, and net profit margin of 36.97%.
Gross Margin89.89%
Operating Margin36.04%
Pretax Margin43.59%
Net Profit Margin36.97%
EBITDA Margin38.37%
EBIT Margin35.94%
Analyst Forecast
The average price target for Hansoh Pharmaceutical Group Company Limited is HK$46.44, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$46.44
Price Target Upside16.79% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast22.62%
EPS Growth Forecast26.23%